Authors: Yu Hua, Miao Yingbin, Zhao Shaozhen, Yang Jizhong, Zheng Xiaofen, Han Yuping, Zhao Juwei DOI: 10.3760/cma.j.cn115989-2019-0618-00269 Published 2020-09-10 Cite as Chin J Exp Ophthalmol, 2020,38(09): 767-772. Abstract [View PDF] [Read Full Text] Objective To estimate the correlation between DR and diabetic corneal nerve damage […]
Tag: Diabetic retinopathy
Changes in DNA methylation of retinal gene promoter regions and their significance in type 1 diabetic rats
Authors: Li Yahong, Geng Chao, Liu Shengnan, Wang Qi, Li Xiaorong, Zhang Yan DOI: 10.3760/cma.j.cn115985-20190616-00262 Published 2020-04-10 Cite as Chin J Exp Ophthalmol, 2020,38(04): 291-299. Abstract [View PDF] [Read Full Text] Objective To study the methylation level of retinal gene promoter region […]
NLRP3 inflammasome and eye diseases
Authors: Zhang Yujian, Ji Min, Guan Huaijin DOI: 10.3760/cma.j.cn115989-20200325-00203 Published 2020-04-10 Cite as Chin J Exp Ophthalmol, 2020,38(04): 365-368. Abstract [View PDF] [Read Full Text] Nucleotide binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a set of intracellular […]
Antioxidative effect and mechanism of tert-butyl hydroquinone on rat retinal Müller cells under high glucose condition
Authors:He Wei, Tian Min, Yu Xi, Cao Yang, Zheng Wenli, Lyu Hongbin DOI: 10.3760/cma.j.issn.2095-0160.2020.01.004 Published 2020-01-10 Cite as Chin J Exp Ophthalmol, 2020,38(01): 16-22. Abstract [View PDF] [Read Full Text] Objective To expore the impact of teniary butyl hydroquinone (tBHQ) on Müller […]
Effects of complement dysfunction on diabetic retinopathy
Authors:Liao Yi, Chen Hua DOI: 10.3760/cma.j.issn.2095-0160.2020.01.014 Published 2020-01-10 Cite as Chin J Exp Ophthalmol, 2020,38(01): 68-72. Abstract [View PDF] [Read Full Text] Diabetic retinopathy (DR) is one of the common neuronal and microvascular complications of diabetes, and it is the key cause […]
Comprehensive strategy for cataract patients with diabetes mellitus
Authors: Yan Hong, Bin Yue DOI: 10.3760/cma.j.issn.2095-0160.2019.10.001 Published 2019-10-10 Cite as Chin J Exp Ophthalmol, 2019,37(10): 769-773. Abstract [View PDF] [Read Full Text] As the increases of morbidity of diabetes, the cataract patients with diabetes mellitus requiring surgery is gradually increasing.Compared with age-related cataract, cataract patients with […]
Expression of proline hydroxylase 2 in the membrane of proliferative diabetic retinopathy
Authors: Zhang Han, Lu Qiang, Cui Wei DOI: 10.3760/cma.j.issn.2095-0160.2019.10.003 Published 2019-10-10 Cite as Chin J Exp Ophthalmol, 2019,37(10): 779-784. Abstract [View PDF] [Read Full Text] Objective To investigate the expression of proline hydroxylase 2 (PHD2) in the proliferatine membrane of proliferative diabetic retinopathy (PDR) and its relationship with […]
Prevention and treatment research of fenofibrate for diabetic retinopathy and its clinical translation
Authors: Tan Guilin, Cheng Lingyun DOI: 10.3760/cma.j.issn.2095-0160.2019.10.012 Published 2019-10-10 Cite as Chin J Exp Ophthalmol, 2019,37(10): 828-832. Abstract [View PDF] [Read Full Text] Diabetes is a worldwide prevalent disease and diabetic retinopathy (DR) is one of the common complications, which is vision threatening and even leading to […]
Effects of ubiqutin-proteasome system in retinopathy and their mechanism
Authors: Wang Shuai, Liu Shengqiang DOI: 10.3760/cma.j.issn.2095-0160.2019.10.015 Published 2019-10-10 Cite as Chin J Exp Ophthalmol, 2019,37(10): 843-848. Abstract [View PDF] [Read Full Text] Ubiquitin-proteasome system (UPS) is the important protein degradation system in eukaryotic cells, participates in cell cycle, gene transcription, antigen-presenting, cell proliferation and differentiation, signal […]
The changes of aqueous humor vascular endothelial growth factor and pigment epithelium-derived factor levels before and after intravitreal injection of ranibizumab in proliferative diabetic retinopathy
Authors: Wang Yunpeng, Chen Xiaohong, Chen Meizhu DOI: 10.3760/cma.j.issn.2095-0160.2016.01.012 Published 2016-01-10 Cite as Chin J Exp Ophthalmol, 2016,34(1): 60-64. Abstract [Download PDF] [Read Full Text] Background Intraocular neovascularization is a primary cause of visual reduce in proliferative diabetic retinopathy (PDR), and intravitreal injection of ranibizumab is one of […]